Editas Medicine (EDIT) Capital Expenditures (2015 - 2026)
Editas Medicine's Capital Expenditures was $433,000 in Q3 2025, down 85.2% from $2.92 million a year earlier.
Powered by 
Analysis
Editas Medicine (EDIT) Capital Expenditures (2015 - 2026) Analysis & Trends
On a trailing twelve-month basis, Editas Medicine's Capital Expenditures was $1.09 million through Sep 30, 2025, down 88.7% year-over-year; for FY2024, it was $8.83 million, up 87.0% from FY2023.
- Capital Expenditures shows a five-year compound annual growth rate of 7.4% (FY2019 to FY2024).
- In earlier years, Capital Expenditures was $4.72 million in FY2023 (+14.6%), $4.12 million in FY2022 (-48.4%), $7.98 million in FY2021 (+11.4%) and $7.16 million in FY2020 (+16.1%).
- Quarterly Capital Expenditures has moved between $84,000 (Q1 2021) and $3.49 million (Q2 2024) over five years.
- Compared with a year earlier, Capital Expenditures was higher in three of the last six quarters, with growth averaging 5.9%.
- The best year-over-year quarter for Capital Expenditures over five years was Q2 2024 (growth of 162.1%); the worst was Q1 2021 (a decline of 96.1%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 3.18 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 1.36 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 301.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 1.04 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | -3.30 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 587.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 237.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 573.00 Mn |
| 10 | Editas Medicine | 385.55 Mn | -286.59 Mn | 8.20 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 106,000.00 |
| Mar 31, 2026 | 92,000.00 |
| Dec 31, 2025 | -1.15 Mn |
| Sep 30, 2025 | 433,000.00 |
| Mar 31, 2025 | 114,000.00 |
| Dec 31, 2024 | 540,000.00 |
| Sep 30, 2024 | 2.92 Mn |
| Jun 30, 2024 | 3.49 Mn |
| Mar 31, 2024 | 1.87 Mn |
| Dec 31, 2023 | 1.31 Mn |
| Sep 30, 2023 | 239,000.00 |
| Jun 30, 2023 | 1.33 Mn |
| Mar 31, 2023 | 1.84 Mn |
| Dec 31, 2022 | 624,000.00 |
| Sep 30, 2022 | 614,000.00 |
| Jun 30, 2022 | 632,000.00 |
| Mar 31, 2022 | 2.25 Mn |
| Dec 31, 2021 | 2.85 Mn |
| Sep 30, 2021 | 2.34 Mn |
| Jun 30, 2021 | 2.70 Mn |
API Access
Editas Medicine Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=EDIT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "EDIT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=EDIT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();